CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy VP Research and Development bought 5,000 shares at $3.96 ($19,778)
- 4 Open-market buy Chief Financial Officer bought 30,000 shares at an average $4.04 ($121,330)
- 4 Option exercise VP Research and Development acquired 13,926 shares (option exercise)
- 4 Option exercise VP of Reg. and Clin. Affairs acquired 6,650 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Technology Officer acquired 65,000 shares (grant or award)
- 4 Grant or award VP of Reg. and Clin. Affairs acquired 60,000 shares (grant or award)
- 4 Grant or award VP of Finance acquired 502 shares (grant or award)
- 4 Grant or award President & CEO acquired 808 shares (grant or award)
- 4 Grant or award VP of Operations acquired 942 shares (grant or award)
- 4 Grant or award VP Research and Development acquired 1,743 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 1,860 shares (grant or award)
Page 9 of 13 · 243 filings